News | March 28, 2022
Aurobindo enters domestic formulations space with the acquisition of Veritaz for Rs 171 Cr
Veritaz has over 40 brands marketed across the acute and critical care therapeutic segments
Veritaz has over 40 brands marketed across the acute and critical care therapeutic segments
Partners with GITAM University to train 27 employees through a 10-day HR module and make them future-ready
With the implementation of this project, a total of 1,030 acres of cultivable land can be irrigated per crop cycle
CuraTeQ and Orion had entered into a licensing agreement, granting marketing and distribution rights for CuraTeQ’s biosimilar products under development in the Nordic states, Austria, Hungary and Slovenia
The brand is now available pan-India through their distribution partner
The drug will be marketed under the brand name Molnaflu
The Board of Directors of Aurobindo Pharma have approved the unaudited consolidated financial results of the company for the period ended September 30, 2021
The site's strategic location in the logistics hubs of the Auvergne Rhone-Alpes region is an advantage, along with the benefit of geographical proximity to Arrow's headquarters in Lyon
CuraTeQ Biologics is on track for filing a second oncology biosimilar
The product will be available in 500 mg/2.5 mL and 1 g/5 mL vials
Subscribe To Our Newsletter & Stay Updated
